Mr.An Yubao (安郁宝) Chalrman and Executive Director

Please refer to the annual report recently issued by Consun Pharmaceutical Group.


Li Qian (黎倩)  Vice Chairman and President

Mrs. Li Qian is Vice Chairman, President and one of the founders of Consun Pharmaceutical Group and the Chairman of Consun’s subsidiary Guangzhou Consun Pharmaceutical Co. Ltd and the Executive Director of Consun’s subsidiary Guangxi Yulin Pharmaceutical Group(referred to as Yulin Pharmaceutical), primarily responsible for corporate strategy formulation and overall management.

Mrs. Li has over 28 years of experience in pharmaceutical industry and engaged in medical education for nearly 10 years. Mrs. Li once worked in Southern Medical University from October 1989 to April 1998. Mrs. Li joined Consun in 1997 when Consun was newly set-up as Deputy Director of the General Manager’s Office and Human Resources Manager, then Deputy Administrative General Manager and Deputy Sales General Manager of Consun’s subsidiary Guangzhou Consun Pharmaceutical Co. Ltd. Since November 1999, Mrs. Li has served as Director and General Manager of Guangzhou Consun, which was redesignated as President in May 200. She has served as Vice Chairman of Consun Pharmaceutical Group since June 1, 2018.

Mrs. Li obtained her MBA from Asia International Open University (Macau) in November 2007. She has obtained 3 invention patents and published research papers on the Chinese Journal of Clinical Medicine (《中国临床医学杂志》). Mrs. Li was awarded as Excellent Private Entrepreneur (优秀民营企业家) by Tongliao Municipal People's Government of the Inner Mongolia Autonomous Region in July 2008 and Model Worker (劳动模范) by Inner Mongolia Autonomous Region People’s Government in April 2010. In December 2010, she won the Third Prize for Science and Technology Progress of Inner Mongolia Autonomous Region (内蒙古自治区科技进步三等奖). In December 2011, she was recognized as Famous Entrepreneur in Pharmaceutical Industry of Guangdong Province (广东省医药行业著名企业家) by Guangdong Pharmaceutical Industry Association (广东省医药行业协会). In April 2014, she was awarded as Chinese Pharmaceutical Brand Woman (中国(医药行业)品牌女性). In February 2017, she was accredited as Excellent Entrepreneur in Pharmaceutical Industry of Guangdong Province (广东省医药行业优秀企业家). In March 2017, she won the First Prize for Science and Technology Progress of Yulin City (玉林市科学技术进步奖一等奖) and in December 2017 she won the Best Business Leader Award by China Finance Magazine.

Mrs. L is a drugstore pharmacist of Guangdong Province (广东省驻店药师) recognized by Guangdong Food and Drug Administration (广东省食品药品监督管理局). She has been appointed as a member of the First Expert Committee for Kidney Disease and Blood Purify of China Medical Women’s Association (第一届中国女医师协会肾脏病及血液净化专家委员会). In October 2014, she was elected as Deputy Director of the Professional Committee of Chinese Medicine Product Development and Incubation of China Association of Traditional Chinese Medicine (中国中药协会中药产品开发与培育专业委员会). In August 2016, she was elected as Deputy Director of the First Expert Committee for Chinese Medicine Development and Research for Kidney Disease of China Association of Traditional Chinese Medicine (中国中药协会第一届肾病中药发展研究专业委员会) and a member of the Pharmacoeconomics Expert Committee (药物经济学专业委员会). In July 2017 she was elected as a member of the Standing Committee of the Encephalopathy Medicine Research Professional Committee of China Association of Traditional Chinese Medicine(中国中药协会脑病药物研究专业委员会).


Zhu Quan (朱荃)  Executive Director and Chief Scientist

Professor Zhu Quan is Executive Director and Chief Scientist of Consun Pharmaceutical Group and the General Manager of Consun’s subsidiary Guangzhou Consun Drug Research Co., Ltd., primarily responsible for science and technology innovation and products research and development.

Professor Zhu has over 30 years of experience in medical education and research and over 10 years of experience in pharmaceutical industry. He was the former Deputy Director of the Medicine College of Nanjing University of Chinese Medicine, Director and doctoral supervisor of National Standardization Laboratory for Chinese Herbal Pharmacology (国家规范化中药药理实验室). Professor Zhu also served as an expert of Science & Technology Commission of Ministry of Education(国家教育部科学技术委员会), an assessment expert of Department of Life Science of National Natural Science Foundation(国家自然科学基金生命科学部) and a drug evaluation expert of Jiangsu Province and the People's Republic of China.

Professor Zhu graduated from the Traditional Chinese Medicine Academy (now known as the Chinese Academy of Traditional Chinese Medicine) in November 1981 and received a master's degree in traditional Chinese medicine. He has served as a professor and doctoral supervisor at Macau University of Science and Technology (澳门科技大学) since September 2003. Professor Zhu joined Consun in August 2006.


Tang Ning(唐宁)  Executive Director and Vice President

Mr. Tang Ning is Executive Director and Vice President of Consun Pharmaceutical Group and Vice General Manager of Consun’s subsidiary Yulin Pharmaceutical, primarily responsible for sales channels management and marketing of medical contrast media.

Mr. Tang joined Consun in July 1998 as Business Manager, Regional Marketing Manager, Marketing Director and President Assistant. He has been Vice President since June 2011 and Executive Director since June 1, 2018.

Mr. Tang graduated from Hunan University of Commerce (湖南商学院) in June 1986, majoring in marketing.


Zhou Shangwen(周尚文)  Vice President

Mr. Zhou Shangwen is Vice President of Consun Pharmaceutical Group, primarily responsible for marketing of kidney diseases medicines of South China and marketing of women’s and children’s medicines across the country.

Mr. Zhou joined Consun in April 2004 as Regional Marketing Manager, Marketing Director and President Assistant. He has been Vice President since July 2013.

Mr. Zhou graduated from Beijing Medical University (北京医科大学) (now known as Peking University Health Science Centre (北京大学医学部)) in July 1995 with a bachelor’s degree in mental health.


Fang Lanfen(方兰芬)  Vice President

Mrs. Fang Lanfen is Vice President of Consun Pharmaceutical Group, primarily responsible for policy affairs and marketing of Rx.

Mrs. Fang joined Consun in July 1999 as Business Manager, Regional Marketing Manager, Marketing Director. She has been Vice President since July 2013. She was appointed as a member of the First Expert Committee for Chinese Medicine Development and Research for Kidney Disease of China Association of Traditional Chinese Medicine(中国中药协会第一届肾病中药发展研究专业委员会) in August 2016.


Mr. Fang Peicheng (方培城), President Assistant and Financial Director

Mr. Fang Peicheng is President Assistant and Financial Director of Consun Pharmaceutical Group, primarily responsible for financial management.

Mr. Fang joined Consun in August 2010 as Audit Manager, Audit and Legal Director. He has been President Assistant since January 2015 and Director of Consun’s subsidiary Consun Pharmaceutical (Inner Mongolia) Co. Ltd since August 2018.

Mr. Fang graduated from Nan Hua College of Industry and Commerce (南华工商学院), majoring in Accounting Computerization in July 2002 and graduated from China University of Petroleum (Eastern China) (中国石油大学(华东)) Accounting Profession with a bachelor’s degree in management in July 2008. Mr. Fang has the Audit Professional Qualification Certificate (Intermediate) granted by the Ministry of Human Resources and Social Security of the People’s Republic of China (中华人民共和国人力资源和社会保障部). He is also a member of the Institute of Internal Auditors.


Mr. Gao Haien (高海恩)  Board Secretary and Company Secretary

Mr. Gao Haien is Board Secretary and Joint Company Secretary of Consun Pharmaceutical Group and Director and Board Secretary of Consun’s subsidiary Yulin Pharmaceutical, primarily responsible for the board of directors, shareholders conferences and securities related matters.

Mr. Gao joined Consun in August 2007 as the Board Secretary. Mr. Gao has been the legal representative of Consun’s subsidiaries Guangzhou Consun Pharmaceutical Co. Ltd, Consun Pharmaceutical (Inner Mongolia) Co. Ltd and Inner Mongolia Kangyuan Pharmaceutical Co. Ltd since March 2013. Mr. Gao has been Director of Consun’s subsidiary Consun Pharmaceutical (Inner Mongolia) Co. Ltd since August 2018.

Mr. Gao graduated from China University of Mining and Technology with a bachelor's degree in engineering in 1992 and a bachelor's degree in economics in 1994. He obtained his MBA from Zhongnan University of Economics and Law in 2012. Mr. Gao has Securities Professional Qualification Certificate (Level 2) issued by the Securities Association of China and Board Secretary Qualification Certificate issued by Shenzhen Stock Exchange. He is also a member of Hong Kong Securities and Investment Institute.


Yau Chi Ming (丘志明)  Company Secretary

Mr. Yau Chi Ming is Joint Company Secretary of Consun Pharmaceutical Group, primarily responsible for secretarial matters.

Mr. Yau has over 20 years of experience in finance and accounting. Mr. Yau joined Consun in March 2013 as Company Secretary. Mr. Yau once worked at an international audit firm from August 1992 to November 1994 and from May 1995 to October 2012.

Mr. Yau graduated from The University of Hong Kong in 1992 with a bachelor’s degree in Social Sciences. Mr. Yau is a certified public accountant and a senior member of the Hong Kong Institute of Certified Public Accountants.